Fresh off an $11.5B car­dio wa­ger, Mer­ck promis­es in­vestors a megablock­buster fu­ture in a re­turn to the glo­ry days

Mer­ck’s de­ci­sion to out­bid Bris­tol My­ers Squibb dur­ing the $11.5 bil­lion auc­tion of Ac­celeron raised the bar con­sid­er­ably for the phar­ma gi­ant’s car­dio­vas­cu­lar drug port­fo­lio …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER